Triptorelin extended release (Foresee Pharmaceuticals)
N/A
Report date: 2025/04/30 20:00:42
Base Information
Drug NameTriptorelin extended release (Foresee Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesForesee Pharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesForesee Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A